ALL ALS consortium launches website to advance ALS research

Newly established clinical research consortium, led by Barrow Neurological Institute and Massachusetts General Hospital, surpasses 300 study participants

2025-03-31

(Press-News.org) ALL ALS Consortium Launches Website to Advance ALS Research

The Access for All in ALS (ALL ALS) Consortium announced the launch of its official website, creating a central hub for information about its initiatives and clinical research studies. ALL-ALS.org is designed to inform and engage researchers, clinicians, and current and prospective study participants.

The ALL ALS Consortium formed in fall 2023 with funding from the National Institutes of Health (NIH). The consortium consists of 35 clinical sites in the United States and Puerto Rico, led by researchers at Barrow Neurological Institute in Phoenix, Arizona and Massachusetts General Hospital in Boston, Massachusetts.

The ALL ALS Consortium has designed and initiated two research protocols. ASSESS ALL ALS is for people living with the disease and healthy people who will act as comparators. PREVENT ALL ALS is for people who may be at genetic risk for ALS but do not have any symptoms of the disease. The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 participants across the ASSESS and PREVENT studies.

“We are incredibly excited to hit the exciting milestone of 300 participants enrolled, and we look forward to reaching our next big milestone of 1,000 participants by fall 2025,” said Robert Bowser, PhD, the Chief Scientific Officer and John P. and Betty Van Denburgh Chair of Neuromuscular Disease at Barrow.

The consortium aims to disrupt the traditional research landscape for Amyotrophic Lateral Sclerosis (ALS) by making its data and samples available to researchers around the world, through both a web-based portal and a central biorepository. These open science practices will help pave the way for transformative discoveries in the field, bringing hope to the ALS community.

The consortium will collect and publish clinical, genomic, and biomarker data and samples through the PREVENT and ASSESS studies. This will help researchers everywhere investigate the causes of ALS onset, progression, prognosis, and response to therapies.

“The size and scope of ALL ALS, the speed of enrollment, and its geographic reach from across the U.S. make ALL ALS special,” said James D. Berry, MD, the Chief of the Division of Motor Neuron Diseases and Director of the Neurological Clinical Research Institute at Mass General Hospital. “And it comes at just the right time. The big data generated by ALL ALS prepares us to leverage new AI models to gain radical new insights into the disease.”

ALS, also known as Lou Gehrig’s disease, is a progressive neurological disease that causes the degeneration of motor neurons resulting in progressive weakness. ALS has no cure, yet. It is estimated that more than 30,000 Americans may be living with ALS at any given time.

“Time is of the essence for people living with ALS and those who may be at genetic risk of developing the disease. We are working to discover new drug targets and approaches to quickly identify more effective treatments,” Drs. Berry and Bowser said. “It’s our hope the All ALS Consortium will lead us to groundbreaking ALS discoveries, treatments, and even prevention strategies.”

If you are interested in learning more about this study, please email Info@ALL-ALS.org. The ALL ALS Consortium is funded by the National Institutes of Health: OT2NS136939 and OT2NS136938.

About Barrow Neurological Institute

Barrow Neurological Institute, located at Dignity Health St. Joseph's Hospital and Medical Center in Phoenix, is an international leader in treatment, research and education relating to brain and spinal diseases and injuries. The Institute is one of the busiest centers for neurology and neurosurgery in the United States. Each year, more than 77,000 patients are treated at Barrow with more than 5,000 neurosurgeries performed at the Institute. Because of its high volume, Barrow clinicians are familiar with the rarest and most challenging neurological conditions and are often sought by patients from around the world for life-saving medical care. About Barrow Neurological Institute.

To learn more about Barrow, please follow us on Facebook, Instagram, LinkedIn and X.

About Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion, and comprises more than 9,500 researchers working across more than 30 institutes, centers, and departments. In July 2024, Mass General was named to the U.S. News & World Report Best Hospitals Honor Roll. MGH is a founding member of the Mass General Brigham health care system.

END

ELSE PRESS RELEASES FROM THIS DATE:

Many TB cases may have gone undetected in prisons in Europe and the Americas during COVID-19

2025-03-31

EMBARGOED UNTIL 6:30 P.M. EST on Monday, March 31, 2025 Contact: Jillian McKoy, jpmckoy@bu.edu Michael Saunders, msaunder@bu.edu ## Many TB Cases May Have Gone Undetected in Prisons in Europe and the Americas During COVID-19 A new study found that reported diagnoses for tuberculosis were consistently lower than expected throughout the pandemic, even though incarceration rates remained largely consistent and TB detection among the general population managed to reverse after an early-pandemic decline. Incarcerated populations have a high risk of developing tuberculosis ...

Predicting older people’s frailty helps doctors intervene earlier

2025-03-31

UNDER EMBARGO UNTIL 00.01 AM BST ON TUESDAY 1 APRIL The new Electronic Frailty Index 2 (eFI2) is now available to 60% of England’s GPs thanks to research funded by the National Institute of Health and Care Research (NIHR) and conducted by researchers at the University of Leeds and UCL GP data on 36 health problems such as dementia, falls and fractures will help medical professionals to more accurately identify older people’s frailty and intervene earlier Interventions may include a holistic assessment and treatment plan, falls prevention, targeted medicines review, and resistance exercise ...

New study validates lower limits of human heat tolerance

2025-03-31

A study from the University of Ottawa’s Human and Environmental Physiology Research Unit (HEPRU) has confirmed that the limits for human thermoregulation—our ability to maintain a stable body temperature in extreme heat—are lower than previously thought. This research, led by Dr. Robert D. Meade, former Senior Postdoctoral Fellow and Dr. Glen Kenny, Director of HEPRU and professor of physiology at uOttawa's Faculty of Health Sciences, highlights the urgent need to address the impacts of climate change on human health. The study found that many regions may soon experience heat and humidity levels that exceed the safe limits ...

UTA takes lead with mobile lab to address rural health care crisis

2025-03-31

Texas has the most rural residents of any state, with nearly 3 million people spread across a vast landscape. If rural Texas were its own state, it would rank as the 36th most populous. Yet, rural Texans face significant barriers to health care that their urban counterparts do not. More than a quarter of the state’s 172 rural counties lack a hospital, and those with at least one hospital often struggle with a shortage of qualified health care personnel, such as nurses and first responders. To address these growing challenges, The University of Texas at Arlington introduced its new Mobile Simulation Lab on Friday. It’s the first in Texas dedicated ...

New flexible hydrogel could improve drug delivery for post-traumatic osteoarthritis treatment

2025-03-31

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on relieving symptoms but do not prevent or stop the progression of the condition. Although emerging therapies have shown promise in preclinical studies, a major obstacle is delivering these therapies effectively into the joint, a highly dynamic environment subjected to constant mechanical stress. Researchers at Mass General Brigham have created a new hydrogel to improve drug delivery for treating PTOA. The hydrogel, ...

Association for Molecular Pathology celebrates U.S. District Court’s decision to vacate FDA rule on laboratory-developed test procedure regulation

2025-03-31

ROCKVILLE, Md. – March 31, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, and pathologist Michael Laposata, M.D., Ph.D., today announced a favorable ruling in their lawsuit against the U.S. Food and Drug Administration over the regulation of laboratory-developed test procedures. The ruling by Judge Sean D. Jordan of the U.S. District Court for the Eastern District of Texas granted AMP’s motion for summary judgment ...

Dr. Christopher Kramer is new American College of Cardiology President

2025-03-31

Christopher M. Kramer, MD, FACC, today assumed the role of president of the American College of Cardiology, an almost 60,000-member global cardiovascular organization working to transform cardiovascular care and improve heart health for all. “I see significant challenges and opportunities for the field of cardiology in the coming years, including workforce issues, health equity, diversity and inclusion, and AI-driven solutions, that need to be addressed to achieve ACC’s mission of transforming cardiovascular care for all,” ...

Dr. David Winchester is new Chair of ACC Board of Governors

2025-03-31

Effective today, David E. Winchester, MD, MS, FACC, will serve as chair of the American College of Cardiology Board of Governors (BOG) and secretary of the Board of Trustees. His term will run one year from 2025-2026. Winchester will lead governors from chapters representing all 50 states, the District of Columbia, Puerto Rico, Canada, Mexico and representatives from the U.S. health services. The BOG serves as the grassroots governing body of the ACC, a leading cardiovascular organization representing over 56,000 cardiovascular care team members around the world. “Being Chair of the Board ...

4:3 Intermittent fasting shows modestly greater weight loss than daily caloric restriction

2025-03-31

Embargoed for release until 5:00 p.m. ET on Monday 31 March 2025 Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but ...

Patient navigators improve colonoscopy rates after abnormal stool tests, study shows

2025-03-31

TUCSON, Arizona — A University of Arizona Health Sciences-led study found that patients are more likely to get colonoscopies following abnormal stool test results if patient navigators assist them through the process. The paper, published in the Annals of Internal Medicine, showed that 55% of patients who were assigned to a patient navigator received follow-up colonoscopies within a year compared with 42.5% of patients who received usual care without a navigator. “It is important for patients with abnormal stool test results to get a colonoscopy as soon as possible to prevent an increased risk of colorectal cancer and later-stage cancer detection,” ...

ALL ALS consortium launches website to advance ALS research

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: